|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | C12N 15/11 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| C12N 5/10 | (2006.01) | ||
| C07K 14/47 | (2006.01) | ||
| C07K 16/30 | (2006.01) | ||
| C07K 16/32 | (2006.01) | ||
| A61K 48/00 | (2006.01) | ||
| C07K 16/18 | (2006.01) | ||
| G01N 33/574 | (2006.01) |
| (11) | Number of the document | 2400018 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11007329.3 |
| Date of filing the European patent application | 2003-11-21 | |
| (97) | Date of publication of the European application | 2011-12-28 |
| (45) | Date of publication and mention of the grant of the patent | 2016-05-04 |
| (46) | Date of publication of the claims translation | 2016-08-10 |
| (30) | Number | Date | Country code |
| 10254601 | 2002-11-22 | DE |
| (72) |
Sahin, Ugur, DE
Türeci, Özlem, DE
Koslowski, Michael, DE
|
| (73) |
Astellas Pharma Inc.,
5-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo 103-8411,
JP
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Navikuose diferencijuotai ekspresuojami geno produktai ir jų panaudojimas |
| IN TUMOURS DIFFERENTIALLY EXPRESSED GENE PRODUCTS AND USE OF THE SAME |
| Payment date | Validity (years) | Amount | |
| 2022-11-03 | 347.00 EUR |